Edition:
United States

Quidel Corp (QDEL.OQ)

QDEL.OQ on NASDAQ Stock Exchange Global Select Market

21.73USD
24 Mar 2017
Change (% chg)

$0.05 (+0.25%)
Prev Close
$21.67
Open
$21.71
Day's High
$21.77
Day's Low
$21.67
Volume
2,178
Avg. Vol
50,812
52-wk High
$23.68
52-wk Low
$15.45

QDEL.OQ

Chart for QDEL.OQ

About

Quidel Corporation is engaged in the development, manufacturing and marketing of diagnostic testing solutions. These diagnostic testing solutions are separated into four product categories: immunoassays, molecular assays, virology and specialty products. The Company sells its products directly to end users and distributors, in... (more)

Overall

Beta: 1.21
Market Cap(Mil.): $714.20
Shares Outstanding(Mil.): 32.95
Dividend: --
Yield (%): --

Financials

  QDEL.OQ Industry Sector
P/E (TTM): -- 47.70 29.72
EPS (TTM): -0.42 -- --
ROI: -3.78 6.90 13.00
ROE: -6.59 10.89 14.15

BRIEF-Quidel reports Q4 gaap loss per share $0.06

* Quidel reports fourth quarter and full year 2016 financial results

Feb 08 2017

BRIEF-Quidel receives FDA clearance for Solana(r) molecular assay

* Quidel receives FDA clearance for its new Solana(r) molecular assay for the detection of herpes simplex virus 1+2 and varicella zoster virus Source text for Eikon: Further company coverage:

Nov 29 2016

BRIEF-Quidel receives FDA clearance for Solana

* Quidel receives FDA clearance for its new Solana strep complete assay for rapid and qualitative detection and differentiation of s. Pyogenes (group a beta-hemolytic streptococcus) and s. Dysgalactiae (pyogenic Group C and C beta-hemolytic streptococcus)

Oct 25 2016

BRIEF-Quidel receives FDA clearance for Solana Influenza A+B Assay

* Quidel receives FDA clearance for its Solana(R) Influenza A+B assay in time for the upcoming 2016-2017 flu season

Sep 27 2016

More From Around the Web

Competitors

Earnings vs. Estimates